Send to

Choose Destination
Dev Med Child Neurol. 1995 Mar;37(3):239-45.

Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians.

Author information

Department of Child and Adolescent Psychiatry, University of Göteborg, Annedals Clinics, Sweden.


Endogenous opioid dysfunction hypotheses for the development of autism are reviewed, along with clinical empirical studies of opiate antagonists in autism and self-injurious behaviour. There is not yet sufficient evidence to suggest the use of opiate antagonists in the treatment of autism. Further research, particularly of natrexone in severe self-injury, is warranted.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center